LBP-032 - Safety and efficacy of ravidasvir plus sofosbuvir 12 weeks in noncirrhotic and 24 weeks in cirrhotic patients with hepatitis C virus genotypes 1, 2, 3 and 6: The STORM-C-1 phase II/III trial
Andrieux-Meyer, I., Tan, S.-S., Salvadori, N., Simon, F., Cressey, T.R., Said, H.R.H.M., Hassan, M.R.A., Omar, H., Tee, H.P., Chan, W.-K., Goh, K.L., Omar, S.F.S., Kamarulzaman, A., Kumar, S., Thongsawat, S., Thetket, K., Avihingsanon, A., Khemnark, S., Thanprasertsuk, S., Piedagne, J.-M., Brenner, J., Siva, S., Asimah, N., Da Silva, N., Pecoul, B., Lallemant, M., Murad, S.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
Safety and efficacy of ravidasvir plus sofosbuvir 12 weeks in noncirrhotic and 24 weeks in cirrhotic patients with hepatitis C virus genotypes 1, 2, 3 and 6: The STORM-C-1 phase II/III trial
Andrieux-Meyer, I., Tan, S.-S., Salvadori, N., Simon, F., Cressey, T.R., Said, H.R.H.M., Hassan, M.R.A., Omar, H., Tee, H.P., Chan, W.-K., Goh, K.L., Omar, S.F.S., Kamarulzaman, A., Kumar, S., Thongsawat, S., Thetket, K., Avihingsanon, A., Khemnark, S., Thanprasertsuk, S., Piedagne, J.-M., Brenner, J., Siva, S., Asimah, N., Da Silva, N., Pecoul, B., Lallemant, M., Murad, S.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article